Melanie Herman has a strong background in financial planning and analysis, with extensive experience in various leadership roles. Melanie has worked at Ligand Pharmaceuticals as the Senior Director of Financial Planning and Analysis, Director of Financial Planning and Analysis, and Chief Accounting Officer and Interim CFO. Prior to their time at Ligand, they were the Controller at Ligand Pharmaceuticals, Inc. and CyDex Pharmaceuticals, Inc. Melanie also served as the Assistant Controller at Entertainment Properties Trust and started their career as a Senior Accountant at KPMG LLP.
Melanie Herman earned a Bachelor's degree in Accounting/Finance from Kansas State University from 1997 to 2001.
January, 2023 - present
January, 2022
May, 2015